Category: Antibodies

Filter By
(+)-15-epi Cloprostenol (+)-15-epi Cloprostenol

(+)-15-epi Cloprostenol

Reference: 10006692-500
€0.00 (tax incl.)
Cloprostenol is a synthetic PGF2α analog and a potent FP receptor agonist. (+)-15-epi Cloprostenol is the 15(S), or 15β-hydroxy enantiomer of (+)-cloprostenol. This epimer is less active by several orders of magnitude...
(+)-15-epi Cloprostenol (+)-15-epi Cloprostenol

(+)-15-epi Cloprostenol

Reference: 10006692-5
€0.00 (tax incl.)
Cloprostenol is a synthetic PGF2α analog and a potent FP receptor agonist. (+)-15-epi Cloprostenol is the 15(S), or 15β-hydroxy enantiomer of (+)-cloprostenol. This epimer is less active by several orders of magnitude...
(+)-15-epi Cloprostenol (+)-15-epi Cloprostenol

(+)-15-epi Cloprostenol

Reference: 10006692-10
€0.00 (tax incl.)
Cloprostenol is a synthetic PGF2α analog and a potent FP receptor agonist. (+)-15-epi Cloprostenol is the 15(S), or 15β-hydroxy enantiomer of (+)-cloprostenol. This epimer is less active by several orders of magnitude...
(+)-15-epi Cloprostenol (+)-15-epi Cloprostenol

(+)-15-epi Cloprostenol

Reference: 10006692-1
€0.00 (tax incl.)
Cloprostenol is a synthetic PGF2α analog and a potent FP receptor agonist. (+)-15-epi Cloprostenol is the 15(S), or 15β-hydroxy enantiomer of (+)-cloprostenol. This epimer is less active by several orders of magnitude...
(+)-5-trans Cloprostenol (+)-5-trans Cloprostenol

(+)-5-trans Cloprostenol

Reference: 10004970-5
€0.00 (tax incl.)
A minor impurity produced in the synthesis of (+)-cloprostenol; 20-fold less active than (+)-cloprostenol in terminating pregnancy in the hamster
(+)-5-trans Cloprostenol (+)-5-trans Cloprostenol

(+)-5-trans Cloprostenol

Reference: 10004970-25
€0.00 (tax incl.)
A minor impurity produced in the synthesis of (+)-cloprostenol; 20-fold less active than (+)-cloprostenol in terminating pregnancy in the hamster
(+)-5-trans Cloprostenol (+)-5-trans Cloprostenol

(+)-5-trans Cloprostenol

Reference: 10004970-10
€0.00 (tax incl.)
A minor impurity produced in the synthesis of (+)-cloprostenol; 20-fold less active than (+)-cloprostenol in terminating pregnancy in the hamster
(+)-5-trans Cloprostenol (+)-5-trans Cloprostenol

(+)-5-trans Cloprostenol

Reference: 10004970-1
€0.00 (tax incl.)
A minor impurity produced in the synthesis of (+)-cloprostenol; 20-fold less active than (+)-cloprostenol in terminating pregnancy in the hamster
(+)-Cloprostenol (+)-Cloprostenol

(+)-Cloprostenol

Reference: 16765-5
€0.00 (tax incl.)
A synthetic analog of PGF2α; an FP receptor agonist and a potent luteolytic agent in rats and hamsters; the optically active, 15(R) enantiomer of cloprostenol responsible for the majority of its biological activity
(+)-Cloprostenol (+)-Cloprostenol

(+)-Cloprostenol

Reference: 16765-10
€0.00 (tax incl.)
A synthetic analog of PGF2α; an FP receptor agonist and a potent luteolytic agent in rats and hamsters; the optically active, 15(R) enantiomer of cloprostenol responsible for the majority of its biological activity
(+)-Cloprostenol (+)-Cloprostenol

(+)-Cloprostenol

Reference: 16765-1
€0.00 (tax incl.)
A synthetic analog of PGF2α; an FP receptor agonist and a potent luteolytic agent in rats and hamsters; the optically active, 15(R) enantiomer of cloprostenol responsible for the majority of its biological activity
(+)-Cloprostenol (sodium salt) (+)-Cloprostenol (sodium salt)

(+)-Cloprostenol (sodium salt)

Reference: 16766-5
€0.00 (tax incl.)
(+)-Cloprostenol (sodium salt) is a more water soluble, crystalline form of (+)-cloprostenol.
(+)-Cloprostenol (sodium salt) (+)-Cloprostenol (sodium salt)

(+)-Cloprostenol (sodium salt)

Reference: 16766-10
€0.00 (tax incl.)
(+)-Cloprostenol (sodium salt) is a more water soluble, crystalline form of (+)-cloprostenol.
(+)-Cloprostenol (sodium salt) (+)-Cloprostenol (sodium salt)

(+)-Cloprostenol (sodium salt)

Reference: 16766-1
€0.00 (tax incl.)
(+)-Cloprostenol (sodium salt) is a more water soluble, crystalline form of (+)-cloprostenol.
(+)-Cloprostenol isopropyl ester (+)-Cloprostenol isopropyl ester

(+)-Cloprostenol isopropyl ester

Reference: 10010016-5
€0.00 (tax incl.)
A synthetic analog of PGF2α; an FP receptor agonist and a potent luteolytic agent in rats and hamsters; the optically active, 15(R) enantiomer of cloprostenol responsible for the majority of its biological activity; a...
(+)-Cloprostenol isopropyl ester (+)-Cloprostenol isopropyl ester

(+)-Cloprostenol isopropyl ester

Reference: 10010016-10
€0.00 (tax incl.)
A synthetic analog of PGF2α; an FP receptor agonist and a potent luteolytic agent in rats and hamsters; the optically active, 15(R) enantiomer of cloprostenol responsible for the majority of its biological activity; a...
(+)-Cloprostenol isopropyl ester (+)-Cloprostenol isopropyl ester

(+)-Cloprostenol isopropyl ester

Reference: 10010016-1
€0.00 (tax incl.)
A synthetic analog of PGF2α; an FP receptor agonist and a potent luteolytic agent in rats and hamsters; the optically active, 15(R) enantiomer of cloprostenol responsible for the majority of its biological activity; a...
(+)-Cloprostenol methyl amide (+)-Cloprostenol methyl amide

(+)-Cloprostenol methyl amide

Reference: 10010495-5
€0.00 (tax incl.)
A more lipid soluble form of (+)-cloprostenol, possibly serving as a prodrug for the bioactive free acid
(+)-Cloprostenol methyl amide (+)-Cloprostenol methyl amide

(+)-Cloprostenol methyl amide

Reference: 10010495-10
€0.00 (tax incl.)
A more lipid soluble form of (+)-cloprostenol, possibly serving as a prodrug for the bioactive free acid
(+)-Cloprostenol methyl amide (+)-Cloprostenol methyl amide

(+)-Cloprostenol methyl amide

Reference: 10010495-1
€0.00 (tax incl.)
A more lipid soluble form of (+)-cloprostenol, possibly serving as a prodrug for the bioactive free acid
(+)-Cloprostenol methyl ester (+)-Cloprostenol methyl ester

(+)-Cloprostenol methyl ester

Reference: 10010115-5
€0.00 (tax incl.)
A more lipid soluble form of (+)-cloprostenol, amenable for certain formulations
(+)-Cloprostenol methyl ester (+)-Cloprostenol methyl ester

(+)-Cloprostenol methyl ester

Reference: 10010115-10
€0.00 (tax incl.)
A more lipid soluble form of (+)-cloprostenol, amenable for certain formulations
(+)-Cloprostenol methyl ester (+)-Cloprostenol methyl ester

(+)-Cloprostenol methyl ester

Reference: 10010115-1
€0.00 (tax incl.)
A more lipid soluble form of (+)-cloprostenol, amenable for certain formulations
(E)-2-Hexadecenal (E)-2-Hexadecenal

(E)-2-Hexadecenal

Reference: 17566-500
€0.00 (tax incl.)
A sphingolipid degradation product that has been shown to induce cytoskeletal reorganization and eventual apoptosis via a JNK-dependent pathway; reacts readily with deoxyguanosine and DNA to form aldehyde-derived DNA...
(E)-2-Hexadecenal (E)-2-Hexadecenal

(E)-2-Hexadecenal

Reference: 17566-5
€0.00 (tax incl.)
A sphingolipid degradation product that has been shown to induce cytoskeletal reorganization and eventual apoptosis via a JNK-dependent pathway; reacts readily with deoxyguanosine and DNA to form aldehyde-derived DNA...
(E)-2-Hexadecenal (E)-2-Hexadecenal

(E)-2-Hexadecenal

Reference: 17566-1
€0.00 (tax incl.)
A sphingolipid degradation product that has been shown to induce cytoskeletal reorganization and eventual apoptosis via a JNK-dependent pathway; reacts readily with deoxyguanosine and DNA to form aldehyde-derived DNA...
(R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide

(R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide

Reference: 9001233-5
€0.00 (tax incl.)
A homolog of LOEA, characterized by the addition of an (R)-α-methyl group at the methylene carbon adjacent to the amide nitrogen
(R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide

(R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide

Reference: 9001233-10
€0.00 (tax incl.)
A homolog of LOEA, characterized by the addition of an (R)-α-methyl group at the methylene carbon adjacent to the amide nitrogen
(R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide

(R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide

Reference: 9001233-1
€0.00 (tax incl.)
A homolog of LOEA, characterized by the addition of an (R)-α-methyl group at the methylene carbon adjacent to the amide nitrogen
(R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide (R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide

(R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide

Reference: 9001234-5
€0.00 (tax incl.)
A homolog of LOEA, characterized by the addition of an (R)-α-methyl group at the methylene carbon adjacent to the amide nitrogen
(R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide (R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide

(R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide

Reference: 9001234-10
€0.00 (tax incl.)
A homolog of LOEA, characterized by the addition of an (R)-α-methyl group at the methylene carbon adjacent to the amide nitrogen
(R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide (R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide

(R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide

Reference: 9001234-1
€0.00 (tax incl.)
A homolog of LOEA, characterized by the addition of an (R)-α-methyl group at the methylene carbon adjacent to the amide nitrogen
(R)-3-hydroxy Myristic Acid (R)-3-hydroxy Myristic Acid

(R)-3-hydroxy Myristic Acid

Reference: 16871-50
€0.00 (tax incl.)
A form of the myristic acid that is found in the lipid A component of some Gram negative bacteria, including Escherichia, Haemophilus, Actinobacillus, and Campylobacter species.
(R)-3-hydroxy Myristic Acid (R)-3-hydroxy Myristic Acid

(R)-3-hydroxy Myristic Acid

Reference: 16871-25
€0.00 (tax incl.)
A form of the myristic acid that is found in the lipid A component of some Gram negative bacteria, including Escherichia, Haemophilus, Actinobacillus, and Campylobacter species.
(R)-3-hydroxy Myristic Acid (R)-3-hydroxy Myristic Acid

(R)-3-hydroxy Myristic Acid

Reference: 16871-100
€0.00 (tax incl.)
A form of the myristic acid that is found in the lipid A component of some Gram negative bacteria, including Escherichia, Haemophilus, Actinobacillus, and Campylobacter species.
(R)-3-hydroxy Myristic Acid (R)-3-hydroxy Myristic Acid

(R)-3-hydroxy Myristic Acid

Reference: 16871-10
€0.00 (tax incl.)
A form of the myristic acid that is found in the lipid A component of some Gram negative bacteria, including Escherichia, Haemophilus, Actinobacillus, and Campylobacter species.
(R)-Butaprost (R)-Butaprost

(R)-Butaprost

Reference: 13745-5
€0.00 (tax incl.)
Butaprost is a structural analog of PGE2 with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and...
(R)-Butaprost (R)-Butaprost

(R)-Butaprost

Reference: 13745-10
€0.00 (tax incl.)
Butaprost is a structural analog of PGE2 with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and...
(R)-Butaprost (R)-Butaprost

(R)-Butaprost

Reference: 13745-1
€0.00 (tax incl.)
Butaprost is a structural analog of PGE2 with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and...
(R)-Butaprost (free acid) (R)-Butaprost (free acid)

(R)-Butaprost (free acid)

Reference: 10006045-500
€0.00 (tax incl.)
Butaprost is a structural analog of PGE2 with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and...
(R)-Butaprost (free acid) (R)-Butaprost (free acid)

(R)-Butaprost (free acid)

Reference: 10006045-5
€0.00 (tax incl.)
Butaprost is a structural analog of PGE2 with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and...
(R)-Butaprost (free acid) (R)-Butaprost (free acid)

(R)-Butaprost (free acid)

Reference: 10006045-10
€0.00 (tax incl.)
Butaprost is a structural analog of PGE2 with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and...
(R)-Butaprost (free acid) (R)-Butaprost (free acid)

(R)-Butaprost (free acid)

Reference: 10006045-1
€0.00 (tax incl.)
Butaprost is a structural analog of PGE2 with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and...
(R)-α-Lipoic Acid (R)-α-Lipoic Acid

(R)-α-Lipoic Acid

Reference: 27299-5
€0.00 (tax incl.)
A cyclic disulfide antioxidant; acts as a cofactor in 2-oxo dehydrogenase complex reactions and is reduced to DHLA; decreases serum levels of MDA and increases the activity of SOD and T-AOC in a mouse model of...
(R)-α-Lipoic Acid (R)-α-Lipoic Acid

(R)-α-Lipoic Acid

Reference: 27299-25
€0.00 (tax incl.)
A cyclic disulfide antioxidant; acts as a cofactor in 2-oxo dehydrogenase complex reactions and is reduced to DHLA; decreases serum levels of MDA and increases the activity of SOD and T-AOC in a mouse model of...
(R)-α-Lipoic Acid (R)-α-Lipoic Acid

(R)-α-Lipoic Acid

Reference: 27299-10
€0.00 (tax incl.)
A cyclic disulfide antioxidant; acts as a cofactor in 2-oxo dehydrogenase complex reactions and is reduced to DHLA; decreases serum levels of MDA and increases the activity of SOD and T-AOC in a mouse model of...
(R)-α-Lipoic Acid (R)-α-Lipoic Acid

(R)-α-Lipoic Acid

Reference: 27299-1
€0.00 (tax incl.)
A cyclic disulfide antioxidant; acts as a cofactor in 2-oxo dehydrogenase complex reactions and is reduced to DHLA; decreases serum levels of MDA and increases the activity of SOD and T-AOC in a mouse model of...
(S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide (S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide

(S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide

Reference: 9001236-5
€0.00 (tax incl.)
A homolog of LOEA, characterized by the addition of an (S)-α-methyl group at the methylene carbon adjacent to the amide nitrogen
(S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide (S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide

(S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide

Reference: 9001236-10
€0.00 (tax incl.)
A homolog of LOEA, characterized by the addition of an (S)-α-methyl group at the methylene carbon adjacent to the amide nitrogen
(S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide (S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide

(S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide

Reference: 9001236-1
€0.00 (tax incl.)
A homolog of LOEA, characterized by the addition of an (S)-α-methyl group at the methylene carbon adjacent to the amide nitrogen
(S)-α-Methylbenzyl Ricinoleamide (S)-α-Methylbenzyl Ricinoleamide

(S)-α-Methylbenzyl Ricinoleamide

Reference: 17546-5
€0.00 (tax incl.)
A fatty acid amide derived from ricinoleic acid and methyl benzylamine that demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell...
(S)-α-Methylbenzyl Ricinoleamide (S)-α-Methylbenzyl Ricinoleamide

(S)-α-Methylbenzyl Ricinoleamide

Reference: 17546-25
€0.00 (tax incl.)
A fatty acid amide derived from ricinoleic acid and methyl benzylamine that demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell...

Menu

Settings

Please sign in first.

Sign in